Surveillance methods to monitor the impact of HIV therapy programmes in resource-constrained countries

AIDS, Supplement

Volumn 19, Issue 2, 2005, Pages

  Diaz, Theresa ^a,d   Loth, George ^b   Whitworth, James ^c   Sutherland, Donald ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antiretroviral therapies; HIV; Monitoring; Resource constrained countries; Surveillance

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOPSY; COHORT ANALYSIS; DRUG SURVEILLANCE PROGRAM; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV EDUCATION; MEDICAL SOCIETY; OPPORTUNISTIC INFECTION; PATIENT MONITORING; RESOURCE ALLOCATION; SELF REPORT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPING COUNTRIES; DRUG RESISTANCE, VIRAL; EPIDEMIOLOGIC METHODS; HIV INFECTIONS; HUMANS; MORBIDITY;

EID: 23044469424     PISSN: 13502840     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Pio Marins JR, de Fátima Jamal L, Chen S, S. Hudes E, Barbasa A, Berti de Azevedo Barros M, et al. Sobrevivência atual dos pacientes com aids no Brasil. Evidência dos resultados de um esforço nacional (Survival of AIDS patients in Brazil: Evidence of the results of a National Effort). Boletim Epidemiológico Aids Ano XV no. 02. Year XV, no. 02 Oct 2001-March 2002.
2. Casseb J, Pereira LC, Silva GL, Medeiros LA. Decreasing mortality and morbidity in adult AIDS patients from 1995 to 1997 in São Paulo, Brazil. AIDS Patient Care STDs 1999; 13:213-214.
3. Centers for Disease Control and Prevention. Update: the AIDS epidemic in the United States, 2001. MMWR 2002; 51:592-595.
4. Nakashima AK, Fleming PL. HIV/AIDS surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr 2003; 32 (suppl. 1):S68-S85.
5. World Health Organization. Interim patient monitoring guidelines for HIV care and ART. Available at: www.who.org. Accessed: 27 April 2005.
6. Joint United Nations Programme on HIV/AIDS. Monitoring the declaration of commitment on HIV/AIDS: guidelines on construction of core indicators. Geneva: UNAIDS; 2003. ISBN 92-9173-238-9:25-26.
7. Stover J. AIM version 4: a computer program for HIV/AIDS projections and examining the social and economic impact of AIDS. The Future Group International; Washington, D.C. April 2003. pp. 14-15.
8. Stover J. Projecting the demographic consequences of adult HIV prevalence trends: the Spectrum Projection Package. Sex Transm Infect 2004; 80 (suppl. 1):i14-i18.
9. World Health Organization. Global AIDS surveillance - part 1. Wkly Epidemiol Rec 1997; 72:359.
10. World Health Organization. Workshop on AIDS in Central Africa. WHO/CDS/AIDS 85.1. 1986.
11. De Cock KM, Colebunders R, Francis H, Nzlambi N, Laga M, Ryder RW, et al. Evaluation of the WHO clinical case definition for AIDS in rural Zaire. AIDS 1988; 2:219-221.
12. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR RR 1992; 41:1-17.
13. Pan American Health Organization. Working group on AIDS case definition. Bull Pan Am Health Org 1989; 10:9-11.
14. Weniger BG, Quinhoes EP, Sereno AB, de Perez MA, Krebs JW, Ismael C, et al. A simplified surveillance case definition of AIDS derived from empirical clinical data. The Clinical AIDS Study Group and the Working Group on AIDS case definition. J Acquir Immune Defic Syndr 1992; 5:1212-1223.
15. World Health Organization. WHO case definitions for AIDS surveillance in adults and adolescents. Wkly Epidemiol Rec 1994; 69:273-280.
16. Greenberg AE, Coulibaly IM, Kadio A, Coulibaly D, Kassim S, Sassan-Morokro M, et al. Impact of the 1994 expanded World Health Organization AIDS case definition on AIDS surveillance in university hospitals and tuberculosis centers in Cote d'Ivoire. AIDS 1997; 11:1867-1872.
17. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infections and disease. Wkly Epidemiol Rec 1990; 65:221-224.
18. The WHO International Collaborating Group for the Study of WHO Staging System. Proposed World Health Organisation staging system for HIV infection and disease. Preliminary testing by an international collaborative cross-sectional study. AIDS 1993; 7:711-718.
19. Lifson AR, Allen S, Wolf W, et al. Classification of HIV infection and disease in women from Rwanda. Evaluation of the World Health Organization HIV staging system and recommended modifications. Ann Intern Med 1995; 122:262-270.
20. Malamba SS, Morgan D, Clayton T, Mayanja B, Okongo M, Whitworth J. The prognostic value of the World Health Organisation staging system for HIV infection and disease in rural Uganda. AIDS 1999; 13:2555-2562.
21. Morgan D, Maude GH, Malamba SS, Okongo MJ, Wagner H-U, Mulder DW, Whitworth JA. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997; 350:245-250.
22. Morgan D, Ross A, Mayanja B, Malamba S, Whitworth J. Early manifestations (pre-AIDS) of HIV-1 infection in Uganda. AIDS 1998; 12:591-596.
23. Morgan D, Malamba SS, Orem J, Mayanja B, Okongo M, Whitworth JAG. Survival by AIDS defining condition in rural Uganda. Sex Transm Infect 2000; 76:193-197.
24. French N, Mujugira A, Nakiyingi J, Mulder D, Janoff EN, Gilks CF. Immunologic and clinical stages in HIV-1-infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease. J Acquir Immune Def Syndr 1999; 22:509-516.
25. World Health Organization. WHO Report 2003: Global tuberculosis control: surveillance, planning and financing. WHO/CDS/TB/2003.316.
26. World Health Organization. Interim policy on collaborative TB/HIV activities. WHO/HTM/HIV/2004. 1:3.
27. Selik RM, Karon JM, Ward JW. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J Infect Dis 1997; 176:632-636.
28. Jones JL, Hanson DL, Chu SY, Fleming PL, Hu DJ, Ward JW. Surveillance of AIDS-defining conditions in the United States. Adult/Adolescent Spectrum of HIV Disease Project Group. AIDS 1994; 8:1489-1493.
29. Wensing AM, Boucher CA. Worldwide transmission of drug-resistant HIV. AIDS Rev 2003; 5:140-155.
30. Girardi E. Epidemiological aspects of transmitted HIV drug resistance. Scand J Infect Dis 2003; 35 (suppl. 106):17-20.
31. De Felici A. Global HIV drug resistance surveillance. Scand J Infect Dis 2003; 35 (suppl. 106):21-23.
32. World Health Organization. Draft guidelines for surveillance of HIV drug resistance. Geneva: World Health Organization; 2003.
33. Mathers CD, Bernard C, Moesgaard Iburg K, Inove M, MA Fat D, Shibuya K, et al. Global Burden of Diseases in 2002: data sources, methods and results. Global Programme for Evidence for health policy discussion paper no. 54. Geneva: World Health Organization; 2004.
34. Lopez AD, Ahmad O, Guillot M, Ferguson B, Salomon J, Murray CJ, et al. World mortality in 2000: life table for 191 countries. Geneva: World Health Organization; 2002.
35. In-depth Research Consortium. Population, health and survival at INDEPTH sites. Ottawa, Canada: IDRC; 356 pp. ISBN 0-88936-948-8; January 2002.
36. Tanzania Ministry of Health, Adult Morbidity and Mortality Project and National Sentinel Surveillance Teams. Toward a national sentinel system for health and poverty monitoring in Tanzania. Presented at the American Public Health Association Meeting. Atlanta, GA, 2001.
37. Rommelman V, Setel P, Hemed Y, Mponezya H, Angeles G, Boerma T. Costs and result of information system in Tanzania 2003. No. 1: Description of indicator coverage and systems with preliminary comparative costing. Measure Evaluation, Carolina Population Center, University of North Carolina at Chapel Hill; 2003.
38. Okosun IS, Dever GE. Verbal autopsy: a necessary solution for the paucity of mortality data in the less-developed countries. Ethn Dis 2001; 11:575-577.
39. Chandramohan D, Maude GH, Rodrigues LC, Hayes RJ. Verbal autopsies for adult deaths: issues in their development and validation. Int J Epidemiol 1994; 23:213-222.
40. Chandramohan D, Maude GH, Rodrigues LC, Hayes RJ. Verbal autopsies for adult deaths: their development and validation in a multicentre study. Trop Med Int Health 1998; 3:436-446.
41. Rodriguez L, Reyes H, Tome P, Ridaura C, Flores S, Guiscafre H. Validation of the verbal autopsy method to ascertain acute respiratory infection as cause of death. Indian J Pediatr 1998; 65:579-584.
42. Mobley CC, Boerma JT, Titus S, Lohrke B, Shangula K, Black RE. Validation study of a verbal autopsy method for causes of childhood mortality in Namibia. J Trop Pediatr 1996; 42:365-369.
43. Quigley MA, Chandramohan D, Setel P, Binka F, Rodrigues LC. Validity of data-derived algorithms for ascertaining causes of adult death in two African sites using verbal autopsy. Trop Med Int Health 2000; 5:33-39.
44. Centers For Disease Control and Prevention. Cause-specific adult mortality: evidence from community-based surveillance - selected sites, Tanzania, 1992-1998. MMWR 2000; 49:416-419.
45. Sanders EJ, Araya T, Kebede D, Schaap AJ, Nagelkerke ND, Coutinho RA. Mortality impact of AIDS in Addis Ababa, Ethiopia. AIDS 2003; 17:1209-1216.
46. De Cock KM, Barrere B, Diaby L, La Fontaine MF, Gnaore E, Porter A, et al. AIDS - the leading cause of adult death in the West African City of Abidjan, Ivory Coast. AIDS 1991; 5:393-398.